CIK 0001287098 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MAXCYTE, INC.
Sign in to watch- Ticker
- MXCT
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522210438
- Phone
- 301-517-5556
- Business address
- 9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
- Former names
- MAXCYTE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 42 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-30 | Johnston John Joseph Director | Option exercise · Stock Option (right to buy) 10b5-1 | −2,841 | 8,717 | ||
| 2023-08-29 | Johnston John Joseph Director | Option exercise 10b5-1 | +2,059 | $1.64 | $3K | 122,642 |
| 2023-08-29 | Johnston John Joseph Director | Sale 10b5-1 | −2,059 | $3.70 | $8K | 120,583 |
| 2023-08-29 | Johnston John Joseph Director | Option exercise · Stock Option (right to buy) 10b5-1 | −2,059 | 11,558 | ||
| 2023-08-28 | Johnston John Joseph Director | Option exercise 10b5-1 | +100 | $1.64 | $164 | 120,683 |
| 2023-08-28 | Johnston John Joseph Director | Sale 10b5-1 | −100 | $3.70 | $370 | 120,583 |
| 2023-08-28 | Johnston John Joseph Director | Option exercise · Stock Option (right to buy) 10b5-1 | −100 | 13,617 | ||
| 2023-07-26 | Johnston John Joseph Director | Option exercise 10b5-1 | +5,000 | $1.64 | $8K | 125,583 |
| 2023-07-26 | Johnston John Joseph Director | Sale 10b5-1 | −5,000 | $4.75 | $24K | 120,583 |
| 2023-07-26 | Johnston John Joseph Director | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 13,717 | ||
| 2023-07-12 | Doerfler Douglas President and CEO | Option exercise 10b5-1 | +16,757 | $0.04 | $670 | 349,954 |
| 2023-07-12 | Doerfler Douglas President and CEO | Sale 10b5-1 | −16,757 | $5.02 | $84K | 333,197 |
| 2023-07-12 | Doerfler Douglas President and CEO | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −16,757 | 235,080 | ||
| 2023-07-11 | Doerfler Douglas President and CEO | Option exercise 10b5-1 | +12,798 | $0.04 | $512 | 345,995 |
| 2023-07-11 | Doerfler Douglas President and CEO | Sale 10b5-1 | −12,798 | $5.04 | $65K | 333,197 |
| 2023-07-11 | Doerfler Douglas President and CEO | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −12,798 | 251,837 | ||
| 2023-07-10 | Doerfler Douglas President and CEO | Option exercise 10b5-1 | +445 | $0.04 | $18 | 333,642 |
| 2023-07-10 | Doerfler Douglas President and CEO | Sale 10b5-1 | −445 | $5.01 | $2K | 333,197 |
| 2023-07-10 | Doerfler Douglas President and CEO | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −445 | 264,635 | ||
| 2023-06-27 | Johnston John Joseph Director | Option exercise 10b5-1 | +7,471 | $1.64 | $12K | 128,054 |
Page 10 of 15 · 282 trades